QVF
- 产品代码
- QVF
- 器械名称
- Simple Point-Of-Care Device To Directly Detect Sars-Cov-2 Viral Targets From Clinical Specimens In Near-Patient Settings
- 管理类别
- 第 2 类(Class II)
- 21 CFR 条款
- 21 CFR 866.3982
- FDA 专业组
- Microbiology
- 上市路径
- 需提交 510(k) 上市前通告
- 该代码近三年的 510(k)
- 8 件
- 其中 Summary 已存档
- 6 份,可直接下载
- FDA 历史累计 510(k)
- 9 件(全部年份;本站只收录近三年的明细)
FDA 分类定义
A simple point-of-care device to detect SARS-CoV-2 viral targets directly from clinical specimens in near-patient settings is an in vitro diagnostic device for the direct detection of SARS-CoV-2 in clinical specimens and is intended as an aid in the diagnosis of SARS-CoV-2 infections COVID-19). The device is simple to use and does not involve sample manipulation, transportation of the sample to another functional area (e.g., a central laboratory or other specialized area), or measurement of reagents or analytes that could be affected by conditions such as sample turbidity or cell lysis. The design and procedures of the device are appropriate for use by healthcare professionals in near-patient settings outside a centralized laboratory
该代码近三年的 510(k)(8 件)
| 510(k) 号 | 批准日期 | 申请人 | 器械名称 | 摘要 |
|---|---|---|---|---|
| K253882 | 2026-06-01 | CorDx, Inc. | CorDx Tyfast COVID-19 Ag Rapid Test Rx | |
| K251289 | 2025-10-22 | Guangzhou Wondfo Biotech Co., Ltd. | WELLlife COVID-19 Antigen Test Rx | FDA |
| K243872 | 2025-06-16 | Becton, Dickinson and Company | BD Veritor System for SARS-CoV-2 | |
| K250273 | 2025-06-13 | Abbott Diagnostics Scarborough, Inc. | BinaxNOW COVID-19 Ag Card | |
| K233358 | 2024-08-23 | InBios International, Inc. | SCoV-2 Ag Detect Rapid Test | — |
| K232377 | 2024-04-19 | Healgen Scientific,, LLC | Healgen Rapid COVID-19 Antigen Test | |
| K231187 | 2024-01-23 | Nano-Ditech Corporation | Nano-Check COVID-19 Antigen Test | |
| K233688 | 2023-12-13 | Quidel Corporation | Sofia 2 SARS Antigen+ FIA; Sofia 2 SARS Antigen+ FIA… |
FDA 官方分类页: QVF
分类与上市路径以 FDA 现行公告为准。本页数据来自 openFDA(CC0 公有领域),不构成注册策略建议。